Sebia (France)

Recent papers from Sebia (France)

1. A Scoring System Using Visual and Artificial Intelligence Analysis Quantifies HEp-2 Cell Slide Quality for Optimal Antinuclear Antibody Testing 2253905The Journal of Immunology · 2026
2. Clonotypic peptide mass spectrometry to monitor m-protein reduction in patients with relapsed/refractory multiple myeloma from ikema StudyBlood · 2025
3. Methylglyoxal-Induced Glycation of Plasma Albumin: From Biomarker Discovery to Clinical Use for Prediction of New-Onset Diabetes in Individuals with PrediabetesClinical Chemistry · 2025
4. Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple MyelomaPharmaceutics · 2025
5. Biographical Feature: In memoriam Pierre Tiollais (1934–2024)Journal of Virology · 2025
6. B-241 Next-generation monitoring: M-inSightclinical application in multiple myelomaClinical Chemistry · 2024
7. An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patientsClinical Chemistry and Laboratory Medicine (CCLM) · 2024
8. Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejectionEuropean Journal of Epidemiology · 2024
9. Isatuximab-Specific Immunofixation Electrophoresis Assay to Remove Interference in Serum M-Protein Measurement in Patients with Multiple MyelomaThe Journal of Applied Laboratory Medicine · 2024
10. M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibratorClinical Chemistry and Laboratory Medicine (CCLM) · 2023
11. Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometryBlood Cancer Journal · 2023
12. Bifurcation Left Main Stenting with or without intracoronary imaging: Outcomes From the EBC MAIN trial2023
13. Hb Alessandria [β37(C3)Trp→Leu; HBB: c.113G>T]: a Novel Variant on the β-Globin Chain with Slightly Increased Affinity for Oxygen Detected by Capillary ElectrophoresisHemoglobin · 2022
14. Establishing reference intervals for von Willebrand factor multimersJournal of Medical Biochemistry · 2022
15. Vaccination endpoints: mucosal PCR or Covid-19 disease?Virologie · 2021
16. Hb A2-Pistoia [δ89(F5)Ser→Asn, HBD: c.269G>a]: a Novel Mutation on the δ-Globin Gene in an Italian ChildHemoglobin · 2020
17. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteinsClinical Chemistry and Laboratory Medicine (CCLM) · 2020
18. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresisClinical Chemistry and Laboratory Medicine (CCLM) · 2020
19. Toxicity of essential oils: A brief overview of bioassaysAdvanced technologies · 2020
20. Evaluation of a semi-automatic isoelectric focusing method for apolipoprotein E phenotypingPractical Laboratory Medicine · 2019